Digital Shift in the Publishing-Related Business
First written in FY2022. 8 of 10 entries say "Advanced", first in FY2023-Q1. Latest entry: FY2026.
1 other company's latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「In the publishing-related business, Medical Quall Co., Ltd. is expanding its convention business, which operates lectures and other events for pharmaceutical manufacturers and medical organizations, as well as its compliance services business, which verifies whether pharmaceutical manufacturers' materials and other content comply with various regulations. In July 2025, we also operated the Healthy Heart Symposium.」
We continued to expand the convention and compliance services businesses and operated the Healthy Heart Symposium in July 2025. - FY2026-H1AdvancedAnnual report
「In the publishing-related business, Medical Quall Co., Ltd. is expanding its convention business, which operates lectures and other events for pharmaceutical manufacturers and medical organizations, as well as its compliance services business, which verifies whether pharmaceutical manufacturers' materials and other content comply with various regulations. In July 2025, we also operated the Healthy Heart Symposium.」
The convention and compliance services businesses expanded, and we operated the Healthy Heart Symposium in July 2025. - FY2025-H1AdvancedAnnual report
「In the publishing-related business, in addition to our existing materials production business, the convention and compliance services businesses, among others, are expanding. In July 2024, we operated the AED 20th Anniversary Symposium, and in September 2024, we operated the Healthy Heart Symposium.」
The convention and compliance services businesses, among others, expanded in the publishing-related business, and we operated symposia in July and September 2024. - FY2024AdvancedAnnual report
「In February 2024, we operated the Go Red For Japan health seminar “Women’s Hearts and Heart Health,” hosted by the Japan Cardiovascular Association.」
In the publishing-related business, we operated a cardiovascular health seminar for women hosted by the Japan Cardiovascular Association in February 2024. - FY2024-Q3RestatedAnnual report
「In the publishing-related business, we provide existing customers with high-growth materials, including materials related to oncology and digital materials, while expanding transactions with customers outside the pharmaceutical industry, such as academic societies. We will also expand the convention business, which is expected to generate stable earnings, and provide high-quality services that comply with various regulations by combining the newly launched compliance services business with our existing materials production business.」
The policy of expanding oncology-related and digital materials, customers outside the pharmaceutical industry, the convention business, and the compliance services business remains in place. - FY2024-Q1AdvancedAnnual report
「In the publishing-related business, we provide existing customers with high-growth materials, including materials related to oncology and digital materials, while expanding transactions with customers outside the pharmaceutical industry, such as academic societies. We will also expand high-margin businesses, including the newly launched convention and compliance services businesses.」
We are advancing the provision of oncology-related and digital materials and developing customers outside the pharmaceutical industry, while seeking to expand high-margin businesses, including the new convention and compliance services businesses. - FY2023-Q3AdvancedAnnual report
「In the publishing-related business, the operating structure for the newly launched compliance business, in addition to our existing lecture and streaming businesses, is now in place, and we are focusing on business expansion.」
In the publishing-related business, the operating structure for the newly launched compliance business is now in place, and the business is moving into the expansion phase. - FY2023-Q2AdvancedAnnual report
「In the publishing-related business, we are expanding our convention business, which can accommodate hybrid operations combining in-person lectures with Web streaming, and have newly launched a compliance services business that verifies whether pharmaceutical manufacturers' materials and other content comply with various regulations, on which we are focusing for expansion.」
In addition to expanding the hybrid convention business, we newly launched a compliance services business that verifies whether pharmaceutical manufacturers' materials and other content comply with regulations. - FY2023-Q1AdvancedAnnual report
「In the publishing-related business, we are expanding our Web content production business and our convention business, which can accommodate hybrid operations combining in-person lectures with Web streaming, while advancing our response to the shift toward digital.」
In the publishing-related business, we are expanding Web content production and hybrid convention services combining in-person lectures with Web streaming, while advancing our response to the shift toward digital. - FY2022First statedAnnual report
「In the publishing-related business, we will expand our web content production business and convention business, which can also accommodate hybrid operations combining live lectures with web streaming, in order to respond to the shift toward digital.」
The company first explicitly stated its policy of expanding Web content production and hybrid convention services combining in-person lectures with Web streaming in the publishing-related business.